Alleviation of murine leukemia virus repression in embryonic carcinoma cells by genetically engineered primer binding sites and artificial tRNA primers

Virology

Volumn 278, Issue 2, 2000, Pages 368-379

  Modin, Charlotte ^a   Lund, Anders H ^a   Schmitz, Alexander ^a   Duch, Mogens ^a   Pedersen, Finn Skou ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Embryonal carcinoma; Murine leukemia virus; Primer binding site; Silencing; TRNA

Indexed keywords

COMPLEMENTARY DNA; PRIMER RNA; PROLINE; TRANSFER RNA;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL STRAIN 3T3; CONTROLLED STUDY; DNA SEQUENCE; EMBRYONAL CARCINOMA; FIBROBLAST; GENE SILENCING; GENETIC ENGINEERING; GENETIC TRANSFECTION; HOST RESISTANCE; MARKER GENE; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROVIRUS; RETROVIRUS; REVERSE TRANSCRIPTION; RNA SYNTHESIS; VIRUS INHIBITION; VIRUS REPLICATION;

MURINAE; MURINE LEUKEMIA VIRUS;

EID: 0034534398     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0683     Document Type: Article

References (51)

1. Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells
2. Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5
3. Alkaline phosphatase activity in mouse teratoma
4. Retrovirus-mediated insertion of expressed and non-expressed genes at identical chromosomal locations
5. Rearrangement of the oncogene c-mos in mouse myeloma NSI and hybridomas
6. Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA
7. Studies on the restriction of ecotropic murine retrovirus replication in mouse teratocarcinoma cells
8. Two blocks in Moloney murine leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined by transient expression assays
9. A detailed model of reverse transcription and tests of crucial aspects
10. A new technique for the assay of infectivity of human adenovirus 5 DNA
11. Embryonic stem cell virus, a recombinant murine retrovirus with expression in embronic stem cells
12. The primer for Moloney murine leukemia virus DNA synthesis: Nucleotide synthesis and aminoacylation of tRNAPro
13. De nero methylation and expression of retroviral genomes during mouse embryogenesis
14. Characterization of the Moloney leukemia virus stem cell-specific repressor binding site
15. Proviral sequences that restrict retroviral expression in mouse embryonal carcinoma cells
16. Negative regulation of retrovirus expression in embryonal carcinoma cells mediated by an intragenic domain
17. Evidence for a stem cell-specific repressor of Moloney murine leukemia virus expression in embryonal carcinoma cells
18. Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication
19. Complementation of a primer binding site-impaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer
20. Selection of functional tRNA primers and primer binding site sequences from a retroviral combinatorial library: Identification of new functional tRNA primers in murine leukemia virus replication
21. Replication and pathogenicity of primer binding site mutants of SL3-3 murine leukemia viruses
22. Ser(CGA) functional in murine leukemia virus replication
23. Nucleotide sequencing of an apparent proviral copy of env mRNA defines determinants of expression of the mouse mammary tumor virus env gene
24. Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus
25. Extended minus-strand DNA as template for R-U5-mediated second-strand transfer in recombinational rescue of primer binding site-modified retroviral vectors
26. A preferred region for recombinational patch repair in the 5′ untranslated region of primer binding site-impaired murine leukemia virus vectors
27. Comparison of DNA polymerases for quantification of single nucleotide differences by primer extension analysis
28. Lack of shielding of PBS-silencer mediated repression of an internal promoter in a retroviral vector by the putative insulators scs, BEAD-1 and HS4
29. Nucleotide sequence analysis of endogenous murine leukemia virus-related proviral clones reveals primer-binding sites for glutamine tRNA
30. Phe as a putative primer tRNA
31. A novel sequence segment and other nucleotide structural features in the long terminal repeat of a BALB/c mouse genomic leukemia virus-related DNA clone
32. Different relative expression from two murine leukemia virus long terminal repeats in unintegrated transfected DNA and in integrated retroviral vector proviruses
33. Identification of new eucaryotic tRNA genes in genomic DNA data-bases by a multistep weight matrix analysis of transcriptional control regions
34. Production of high-titer helper-free retroviruses by transient transfection
35. Low-molecular-weight RNAs of Moloney murine leukemia virus, identification of the primer for RNA-directed DNA synthesis
36. A stem cell-specific silencer in the primer-binding site of a retrovirus
37. Lys primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription
38. Structure and in vitro transcription of tRNA gene clusters containing the primers of MuLV reverse transcriptase
39. Small RNAs of Rous sarcoma virus: Characterization by two-dimensional polyacrylamide gel electrophoresis and fingerprint analysis
40. Human adult T-cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA
41. Nucleotide sequence of the visna lentivirus: Relationship to the AIDS virus
42. Nucleotide sequence of Mason-Pfizer monkey virus: An immunosuppressive D-type retrovirus
43. Transcription of eucaryotic tRNA genes
44. De novo methylation, expression, and infectivity of retroviral genomes introduced into embryonal carcinoma cells
45. Mouse teratocarcinoma cells: Prospects for the study of embryogenesis and neoplasia
46. Virus infection of murine teratocarcinoma stem cell lines
47. Nucleotide sequences complemented with functional and structural analysis
48. Cis-acting elements that mediate the negative regulation of moloney murine leukemia virus in mouse early embryos
49. Nucleotide sequence of the AIDS virus
50. Two distinct sequence elements mediate retroviral gene expression in embryonal carcinoma cells
51. Stem cell factor binding to retrovirus primer binding site silencers